Citigroup’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.6K | Buy |
24,756
+22,464
| +980% | +$33.2K | ﹤0.01% | 4180 |
|
|
2025
Q1 | $5.87K | Buy |
2,292
+1,660
| +263% | +$4.25K | ﹤0.01% | 4480 |
|
|
2024
Q4 | $1.19K | Buy |
+632
| New | +$1.19K | ﹤0.01% | 4716 |
|
|
2024
Q3 | – | Sell |
-1,307
| Closed | -$1.53K | – | 4892 |
|
|
2024
Q2 | $1.53K | Sell |
1,307
-11,424
| -90% | -$13.4K | ﹤0.01% | 4576 |
|
|
2024
Q1 | $16K | Buy |
12,731
+1,180
| +10% | +$1.49K | ﹤0.01% | 4341 |
|
|
2023
Q4 | $20.6K | Buy |
11,551
+9,658
| +510% | +$17.2K | ﹤0.01% | 4229 |
|
|
2023
Q3 | $3.14K | Sell |
1,893
-16,550
| -90% | -$27.5K | ﹤0.01% | 4100 |
|
|
2023
Q2 | $36.9K | Buy |
+18,443
| New | +$36.9K | ﹤0.01% | 4109 |
|
|
2022
Q2 | – | Sell |
-300
| Closed | – | – | 5642 |
|
|
2022
Q1 | $0 | Buy |
+300
| New | – | ﹤0.01% | 5577 |
|
|
2018
Q1 | – | Sell |
-1,310
| Closed | -$9K | – | 4985 |
|
|
2017
Q4 | $9K | Hold |
1,310
| – | – | ﹤0.01% | 4535 |
|
|
2017
Q3 | $8K | Hold |
1,310
| – | – | ﹤0.01% | 4264 |
|
|
2017
Q2 | $11K | Buy |
+1,310
| New | +$11K | ﹤0.01% | 4118 |
|
|
2017
Q1 | – | Sell |
-58,479
| Closed | -$260K | – | 4891 |
|
|
2016
Q4 | $260K | Buy |
+58,479
| New | +$260K | ﹤0.01% | 3418 |
|
|
2016
Q2 | – | Sell |
-2
| Closed | – | – | 5183 |
|
|
2016
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 5532 |
|
|
2015
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 5594 |
|
|
2015
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 5453 |
|
|
2015
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 5684 |
|
|
2015
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 5603 |
|
|
2014
Q4 | $0 | Sell |
2
-15
| -88% | – | ﹤0.01% | 5566 |
|
|
2014
Q3 | $0 | Sell |
17
-40
| -70% | – | ﹤0.01% | 5543 |
|
|
2014
Q2 | $2K | Sell |
57
-25
| -30% | -$877 | ﹤0.01% | 5125 |
|
|
2014
Q1 | $3K | Sell |
82
-174
| -68% | -$6.37K | ﹤0.01% | 5165 |
|
|
2013
Q4 | $10K | Hold |
256
| – | – | ﹤0.01% | 4827 |
|
|
2013
Q3 | $11K | Buy |
256
+168
| +191% | +$7.22K | ﹤0.01% | 4536 |
|
|
2013
Q2 | $4K | Buy |
+88
| New | +$4K | ﹤0.01% | 4741 |
|